LifeStance Health (LFST) Cash & Current Investments (2021 - 2025)
LifeStance Health (LFST) has disclosed Cash & Current Investments for 5 consecutive years, with $175.5 million as the latest value for Q4 2025.
- Quarterly Cash & Current Investments rose 12.63% to $175.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $175.5 million through Dec 2025, up 12.63% year-over-year, with the annual reading at $175.5 million for FY2025, 12.63% up from the prior year.
- Cash & Current Investments for Q4 2025 was $175.5 million at LifeStance Health, up from $141.8 million in the prior quarter.
- The five-year high for Cash & Current Investments was $276.2 million in Q2 2021, with the low at $36.3 million in Q1 2024.
- Average Cash & Current Investments over 5 years is $125.8 million, with a median of $125.4 million recorded in 2023.
- The sharpest move saw Cash & Current Investments crashed 71.04% in 2024, then soared 272.27% in 2025.
- Over 5 years, Cash & Current Investments stood at $148.0 million in 2021, then fell by 23.63% to $113.0 million in 2022, then crashed by 30.27% to $78.8 million in 2023, then skyrocketed by 97.71% to $155.8 million in 2024, then rose by 12.63% to $175.5 million in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods came in at $175.5 million, $141.8 million, and $130.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.